At the group level, parvalbumin+ interneuron densities were also significantly reduced in the frontal cortex (P < 0.001) and temporal cortex (P < 0.05) of patients with Alpers' syndrome relative to controls (supporting information Figure S3). This evidence concerns the gene PVALB and Alpers syndrome.